辉瑞预计今年营收将达到1020亿美元，分析师平均估计为1060亿。首席执行官称随疫情演变成地方流行病，新冠药物将增长期商业产品。辉瑞公司所预测的2022年销售额和利润低于华尔街预期，该公司的新冠疫苗和最近批准的口服药物预期收入令投资者失望。据周二的一份声明，这家总部位于纽约的制药商预计2022年调整后每股收益为6.35至6.55美元，分析师的估计为6.65美元。辉瑞表示，营收将达到1020亿美元，...
Source Link- 1
- Comment
- Favorite
辉瑞今年新冠疫苗及口服药营收预估低于华尔街预期
市场资讯2022-02-08
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
1
Report
Login to post
No comments yet